LIFECORE BIOMEDICAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.44 USD | +0.31% |
|
+1.74% | +4.04% |
| 04-19 | Lifecore Biomedical Gets Nasdaq Warning Over Delayed Quarterly Report | MT |
| 04-01 | Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024 | CI |
Chart calendar Lifecore Biomedical, Inc.
3ed069d21b.6WyCmF5jA7waX1U8wUB4pOZNHdcQv2M5Xc510u-m36M.oinu7zNXW90jEmB0mAUs8456eb89_AlBbZgCiNvSu8qdBOrLCxBa5HhqFA~7cb0a501563105867eb318f6c1ce2b8e
Past events on Lifecore Biomedical, Inc.
| 01/04/2024 | Q3 2024 Earnings Release (Projected) |
| 31/08/2023 13:30 | Q4 2023 Earnings Call |
| 31/08/2023 12:30 | Q4 2023 Earnings Release |
| 01/06/2023 13:30 | Q3 2023 Earnings Call |
| 01/06/2023 12:15 | Q3 2023 Earnings Release |
| 17/03/2023 12:30 | Q2 2023 Earnings Call |
| 16/03/2023 20:21 | Q2 2023 Earnings Release |
| 17/11/2022 14:00 | Stephens Investment Conference |
| 01/11/2022 15:30 | Annual General Meeting |
| 06/10/2022 13:00 | Q1 2023 Earnings Call |
| 06/10/2022 12:15 | Q1 2023 Earnings Release |
| 10/08/2022 22:00 | FY 2022 Earnings Call |
| 10/08/2022 21:07 | FY 2022 Earnings Release |
| 05/04/2022 22:00 | Q3 2022 Earnings Call |
| 04/04/2022 | Q3 2022 Earnings Release |
| 10/01/2022 15:30 | ICR Conference |
| 05/01/2022 22:00 | Interim 2022 Earnings Call |
| 05/01/2022 21:05 | Interim 2022 Earnings Release |
| 20/10/2021 20:30 | Annual General Meeting |
| 29/09/2021 22:00 | Q1 2022 Earnings Call |
Annual results
| Fiscal Period | May | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 558 556 0.37% | 590 590 0.03% | 544 529 2.89% | 186 184 1.18% | 103 139 -25.59% | 126 |
|
EBITDA Million USD | Released Forecast Spread | 26,1 22,1 18.08% | 22,0 20,9 5.3% | 31,4 28,7 9.55% | 23,0 21,6 6.47% | 5,81 4,29 35.53% | 16,1 |
|
EBIT Million USD | Released Forecast Spread | 5,48 5,21 5.12% | -38,5 -44,2 12.91% | -13,5 -8,02 -68.22% | -38,0 2,39 -1690.04% | -26,1 -24,5 -6.4% | 9,10 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3,64 5,56 -34.54% | -51,3 -53,2 3.49% | -40,5 -37,8 -7.1% | 0,00 0,00 - | -68,7 -52,2 -31.53% | 7,63 |
|
Net income Million USD | Released Forecast Spread | 0,41 1,90 -78.38% | -38,2 -39,3 2.87% | -32,7 -30,2 -8.09% | -97,2 -36,9 -163.8% | -102 -78,3 -30.49% | 6,87 |
|
EPS USD | Released Forecast Spread | 0,01 0,05 -78.57% | -1,31 -1,35 2.6% | -1,12 -1,03 -8.32% | -3,30 -1,35 -145.35% | -3,41 -2,61 -30.65% | 0,22 |
| Announcement Date | 30/07/19 | 11/08/20 | 28/07/21 | 10/08/22 | 31/08/23 | - |
Quarterly results
| Fiscal Period | May | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 140 125 12.24% | 129 129 -0.26% | 43,5 42,9 1.2% | 53,1 48,4 9.63% | 47,6 45,7 4.17% | 43,4 42,7 1.44% | 38,8 48,4 -19.85% | 27,6 28,0 -1.42% | 31,5 29,0 8.69% | 24,4 | 29,8 | 35,7 | 36,4 | 28,6 |
|
EBITDA Million USD | Released Forecast Spread | 12,1 8,21 47.49% | 4,42 3,68 20.16% | 8,30 3,40 144.38% | 6,36 5,77 10.31% | 6,02 6,45 -6.6% | -1,06 1,06 -200.03% | -0,36 6,64 -105.38% | 1,45 2,00 -27.45% | 3,73 4,25 -12.29% | -1,99 | 2,84 | 6,89 | 5,91 | 0,35 |
|
EBIT Million USD | Released Forecast Spread | 1,23 3,15 -60.97% | -3,81 -2,18 -74.95% | 4,14 0,84 395.93% | -3,75 3,19 -217.43% | -35,7 2,33 -1630.89% | -8,16 -2,06 -295.97% | -7,91 2,54 -411.2% | -9,70 -0,98 -892.73% | -5,03 1,25 -502.4% | -4,13 | 2,64 | 4,80 | 5,79 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,44 -0,59 -481.78% | -11,6 -5,17 -124.23% | -41,3 -2,90 -1325.39% | -7,38 -1,11 -564.75% | -36,4 -1,06 -3318.9% | -12,0 -6,10 -96.82% | -12,4 -0,71 -1665.25% | -15,4 -5,28 -191.72% | -33,6 -12,4 -170.82% | -4,50 | 2,24 | 4,43 | 5,46 | |
|
Net income Million USD | Released Forecast Spread | -2,87 -0,42 -579.62% | -9,48 -4,35 -117.79% | -38,4 -2,24 -1616.12% | -12,9 -0,43 -2900.02% | -36,5 -1,45 -2419.15% | -12,1 -5,16 -133.69% | -12,4 -0,63 -1863.56% | -15,5 -5,43 -184.94% | -36,1 -13,6 -165.55% | -4,05 | 2,02 | 3,99 | 4,91 | |
|
EPS USD | Released Forecast Spread | -0,10 -0,02 -525% | -0,32 -0,15 -116.22% | -1,30 -0,10 -1244.78% | -0,43 -0,02 -2479.48% | -1,24 -0,05 -2510.53% | -0,41 -0,18 -134.29% | -0,42 -0,12 -265.22% | -0,51 -0,18 -183.33% | -1,19 -0,45 -167.42% | -0,13 | 0,07 | 0,13 | 0,16 | |
| Announcement Date | 28/07/21 | 29/09/21 | 05/01/22 | 05/04/22 | 10/08/22 | 06/10/22 | 16/03/23 | 01/06/23 | 31/08/23 | - | - | - | - | - |
More events
Past sector events for Lifecore Biomedical, Inc.
| Today | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| Today | AMGEN INC.: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 01/05/2024 11:45 | PFIZER, INC.: Q1 2024 Earnings Release |
| 01/05/2024 08:00 | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
| 01/05/2024 07:00 | GSK PLC: Q1 2024 Earnings Release |
| 30/04/2024 | INNOVIVA, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EYEPOINT PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LFCR Stock
- Calendar Lifecore Biomedical, Inc.
